From: Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study
Covariate
HR (95% CI)
p-value
Age (years), ≥ 63 (vs. < 63)
1.16 (0.41–3.27)
0.78
Cycles of platinum doublet chemotherapy, ≥ 6 (vs. < 6)
0.23 (0.06–0.82)
0.02
Distant metastasis, no (vs. yes)
0.84 (0.30–2.36)
0.74